Written question asked by Lord McLoughlin (Conservative) on Wednesday, 19 January 2005, in the House of Commons. It was due for an answer on Monday, 31 January 2005. It was answered by Baroness Winterton of Doncaster (Labour) on Monday, 31 January 2005 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, which primary care trusts provide the drug Ebixa for the treatment of Alzheimer's disease.

Answer: Mr. McLoughlin: To ask the Secretary of State for Health which primary care trusts provide the drug Ebixa for the treatment of Alzheimer's disease. [210377] Ms Rosie Winterton: Memantine hydrochloride (Ebixa) is licensed for treating moderate to severe Alzheimer's disease. In 2003-04, memantine (Ebixa) was dispensed in the community in England in 265 primary care trusts. This treatment is usually provided under the supervision of hospital-based specialists, so community dispensing information does not give a complete picture of national health service use;

Secondary information